EE9800182A - PGE-1 sisaldavad lüofiliseeritud liposoomid kasutamiseks erektsioonihäire ravis - Google Patents

PGE-1 sisaldavad lüofiliseeritud liposoomid kasutamiseks erektsioonihäire ravis

Info

Publication number
EE9800182A
EE9800182A EE9800182A EE9800182A EE9800182A EE 9800182 A EE9800182 A EE 9800182A EE 9800182 A EE9800182 A EE 9800182A EE 9800182 A EE9800182 A EE 9800182A EE 9800182 A EE9800182 A EE 9800182A
Authority
EE
Estonia
Prior art keywords
treatment
erectile dysfunction
liposomes containing
lyophilized liposomes
containing pge
Prior art date
Application number
EE9800182A
Other languages
English (en)
Inventor
R. See Jackie
Original Assignee
Harvard Scientific Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard Scientific Corporation filed Critical Harvard Scientific Corporation
Publication of EE9800182A publication Critical patent/EE9800182A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EE9800182A 1995-12-15 1996-11-26 PGE-1 sisaldavad lüofiliseeritud liposoomid kasutamiseks erektsioonihäire ravis EE9800182A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/573,408 US5718917A (en) 1995-12-15 1995-12-15 PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
PCT/US1996/018820 WO1997022334A1 (en) 1995-12-15 1996-11-26 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction

Publications (1)

Publication Number Publication Date
EE9800182A true EE9800182A (et) 1998-12-15

Family

ID=24291879

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800182A EE9800182A (et) 1995-12-15 1996-11-26 PGE-1 sisaldavad lüofiliseeritud liposoomid kasutamiseks erektsioonihäire ravis

Country Status (17)

Country Link
US (1) US5718917A (et)
EP (1) EP0874622A4 (et)
JP (1) JPH11504945A (et)
KR (1) KR20000064392A (et)
CN (1) CN1207671A (et)
AU (1) AU722555B2 (et)
BR (1) BR9612040A (et)
EA (1) EA199800565A1 (et)
EE (1) EE9800182A (et)
HU (1) HUP9902094A2 (et)
IL (1) IL124841A (et)
IS (1) IS4767A (et)
NO (1) NO982727L (et)
PL (1) PL327400A1 (et)
SK (1) SK80998A3 (et)
TR (1) TR199801104T2 (et)
WO (1) WO1997022334A1 (et)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050065161A1 (en) * 1996-02-02 2005-03-24 Nitromed, Inc. Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
KR100195348B1 (ko) * 1996-10-31 1999-06-15 장용택 안정한 프로스타글란딘 e1-함유 주사제 조성물
AU742787B2 (en) 1997-07-09 2002-01-10 Androsolutions, Inc. Improved methods and compositions for treating male erectile dysfunction
US6103765A (en) 1997-07-09 2000-08-15 Androsolutions, Inc. Methods for treating male erectile dysfunction
US20020004529A1 (en) * 1997-10-20 2002-01-10 Gary W. Neal Methods, compositions, and kits for enhancing female sexual desire and responsiveness
US6472425B1 (en) 1997-10-31 2002-10-29 Nitromed, Inc. Methods for treating female sexual dysfunctions
US6046240A (en) * 1998-05-01 2000-04-04 Harvard Scientific Corporation Methods for treating female sexual dysfunction
KR100350179B1 (ko) * 1998-09-23 2002-08-27 구주제약주식회사 Ｓｅｄｄｓ로 제제화한 발기부전치료용 주입액제
AU3713600A (en) * 1999-03-01 2000-09-21 Nitromed, Inc. Nitrosated and nitrosylated prostaglandins, compositions and metods of use
CN1314444C (zh) * 2003-03-20 2007-05-09 蔡海德 一种治疗糠尿病及其并发症和病毒性肝炎的组合药物及其制备方法
EP1643972A4 (en) * 2003-06-27 2010-01-20 Smithkline Beecham Corp STABILIZED LIPOSOMAL TOPOTECAN COMPOSITION AND METHOD
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
CN101095944B (zh) * 2007-07-10 2012-04-18 上海市肿瘤研究所 一种预防和治疗前列腺炎穴位缓释贴片及其制品、制备方法和用途
CN101912363A (zh) * 2010-07-29 2010-12-15 蔡海德 溶解超滤-喷雾干燥-分子分散包衣-水化制粒-冷冻干燥生产脂质体组合药物
CN102133182A (zh) * 2010-12-30 2011-07-27 北京中海康医药科技发展有限公司 一种依前列醇脂质体及其制备方法
US9962393B1 (en) * 2015-06-21 2018-05-08 Angiosoma Research, Inc. Method for treating vascular disease by administering a liposomal prostaglandin composition

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US246697A (en) * 1881-09-06 wadleigh
US251355A (en) * 1881-12-27 Edwin h
US3993754A (en) * 1974-10-09 1976-11-23 The United States Of America As Represented By The United States Energy Research And Development Administration Liposome-encapsulated actinomycin for cancer chemotherapy
GB1536215A (en) * 1976-07-05 1978-12-20 Decca Ltd Clamping circuits for television signals
US4086257A (en) * 1976-10-12 1978-04-25 Sears Barry D Phosphatidyl quaternary ammonium compounds
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4533254A (en) * 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
US4677099A (en) * 1981-09-04 1987-06-30 Yeda Research And Development Co., Ltd. Medical processes employing a novel lipid fraction
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
US5040453A (en) * 1982-07-12 1991-08-20 Turn Act Inc. Actuator housing continuation
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US4975282A (en) * 1985-06-26 1990-12-04 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures
US4955878A (en) * 1986-04-04 1990-09-11 Biotechnology, Inc. Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
US4749585A (en) * 1986-04-11 1988-06-07 University Of Medicine And Dentistry Of New Jersey Antibiotic bonded prosthesis and process for producing same
US4776991A (en) * 1986-08-29 1988-10-11 The United States Of America As Represented By The Secretary Of The Navy Scaled-up production of liposome-encapsulated hemoglobin
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
WO1988009170A1 (en) * 1987-05-22 1988-12-01 The Liposome Company, Inc. Prostaglandin-lipid formulations
US4776848A (en) * 1987-07-20 1988-10-11 Anthony Solazzo Urethral fluid application device and system
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US4880835A (en) * 1988-11-03 1989-11-14 Formulations Development Labs, Inc. Oral liquid pharmaceutical compositions of sulindac
JPH0395118A (ja) * 1989-09-07 1991-04-19 Green Cross Corp:The プロスタグランジン含有脂肪小体製剤
US5164320A (en) * 1990-03-05 1992-11-17 Becton, Dickinson And Company Method for lysing hard liposomes using polyethyleneglycol mono-n-alkyl ethers
IT1252603B (it) * 1990-04-19 1995-06-19 Giorgio Cavallini 2,4-diamino-6 piperidino pirimidina-3 ossido topico sul glande nel trattamento delle impotenze erettili
PT97441B (pt) * 1990-04-25 1998-08-31 Alza Corp Processo para a preparacao de composicoes farmaceuticas que compreendem agentes vasodilatadores, nomeadamente, nitratos, alcaloides ergoticos ou prostaglandinas, ou agentes vasoconstritores, nomeadamente, alcoois benzilicos ou benzenodiois substituidos ou ainda agentes antiflamatorios esteroides e nao esteroides e dispositivos para a sua administracao transuretral
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
ES2056337T3 (es) * 1990-11-08 1994-10-01 Boehringer Mannheim Gmbh Utilizacion de antagonistas de receptores de tromboxano-a2 para evitar modificaciones degenerativas en el tejido penil.
US5399581A (en) * 1990-12-26 1995-03-21 Laragh; John H. Method and compositions for treatment of sexual impotence
ES2128343T3 (es) * 1991-05-07 1999-05-16 Liposome Co Inc Formulaciones de prostaglandina liposomica.
JPH05139977A (ja) * 1991-05-17 1993-06-08 Green Cross Corp:The プロスタグランジン類リポソーム複合体を充填した注射器
DE4117249C2 (de) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomin zur Behandlung erektiler Dysfunktionen
AU2300092A (en) * 1991-07-03 1993-02-11 Nathan E. Scott Prostaglandin e2 treatment of impotence
US5422371A (en) * 1992-05-27 1995-06-06 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5370613A (en) * 1993-02-11 1994-12-06 Helmy; Ali M. Catheter apparatus for delivering drugs to the penis
CA2168260C (en) * 1993-07-28 2000-04-11 Marianna Foldvari Biphasic multilamellar lipid vesicles
US5419763B1 (en) * 1994-01-04 1997-07-15 Cor Trak Medical Inc Prostatic drug-delivery catheter
US5482039A (en) * 1994-03-25 1996-01-09 Vivus, Inc. Process for diagnosing erectile dysfunction, and related methods of treatment
KR100422191B1 (ko) * 1994-08-05 2004-05-20 인파머 에스. 에이. 포스페티딜콜린과착물화된프로스타글란딘e1및/또는트록세루틴을함유하는발기불능국부치료용조성물
GB9423910D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
KR20000064392A (ko) 2000-11-06
IL124841A0 (en) 1999-01-26
WO1997022334A1 (en) 1997-06-26
IS4767A (is) 1998-06-09
EP0874622A1 (en) 1998-11-04
EA199800565A1 (ru) 1999-02-25
AU722555B2 (en) 2000-08-03
JPH11504945A (ja) 1999-05-11
NO982727L (no) 1998-08-17
NO982727D0 (no) 1998-06-12
CN1207671A (zh) 1999-02-10
AU1024297A (en) 1997-07-14
IL124841A (en) 2001-01-28
HUP9902094A2 (hu) 1999-10-28
TR199801104T2 (xx) 1998-10-21
BR9612040A (pt) 1999-12-28
EP0874622A4 (en) 1999-02-10
SK80998A3 (en) 1999-01-11
US5718917A (en) 1998-02-17
PL327400A1 (en) 1998-12-07

Similar Documents

Publication Publication Date Title
FI972205A0 (fi) cGmp-PDE:n estäjiä erektiohäiriön hoidossa
CY2006007I2 (el) Χρηση αναστολεων cgmp-φωσφοδιεστερασης στην αγωγη της ανικανοτητας
FI955911A7 (fi) Pyratsolopyrimidinonit impotenssin hoidossa
GB9608408D0 (en) Treatment of erectile dysfunction
EE03512B1 (et) Epinastiin kasutamiseks valude ravis
GR900300093T1 (en) Composition for the treatment of erectile dysfunction
ID17156A (id) Zat-zat anti koagulan yang berguna dalam pengobatan trombosis
PT936908E (pt) Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela)
EE9800182A (et) PGE-1 sisaldavad lüofiliseeritud liposoomid kasutamiseks erektsioonihäire ravis
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
FI963252A7 (fi) Kivun hoitoon tarkoitetut uudet opioidipeptidit ja niiden käyttö
EP1027054A4 (en) LOCAL CONTRIBUTION OF PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF ERECTILE DYSFUNCTION
ID18679A (id) Penggunaan terapi lanjutan
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
EP1079764A4 (en) TREATMENT OF SEXUALITY DISORDERS IN CERTAIN GROUPS OF PATIENTS
BR9709636A (pt) Uso de buckminsterfulereno no tratamento de ferimento neurotóxico
DE4391805T1 (de) Körpertherapiekissen
NO20022101D0 (no) Peptider for behandling av erektil dysfunksjon
GB9603657D0 (en) Improvements in the treatment of vaginal infections
BR9702075A (pt) Derivados de uréida biologicamente ativos úteis no tratamento de esclerose múltipla
IL112681A0 (en) Opioid peptides for the treatment of pain and use thereof
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
NO942963D0 (no) Behandling av erektil dysfunksjon
AU2984399A (en) Pge-1 containing lyopholized liposomes for use in the treatment of erectile dysfunction
GB9622852D0 (en) Treatment of intimal hyperplasma